Illumina PT Raised to $140.00 (ILMN)
Analysts at Leerink Swann upped their target price on shares of Illumina (NASDAQ:ILMN) from $110.00 to $140.00 in a research report issued to clients and investors on Friday, Analyst Ratings Network.com reports. Leerink Swann’s price target suggests a potential upside of 11.77% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Bank of America Corp. raised their price target on shares of Illumina from $125.00 to $165.00 in a research note to investors on Friday. Separately, analysts at Robert W. Baird raised their price target on shares of Illumina from $87.00 to $137.00 in a research note to investors on Friday. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of Illumina from $120.00 to $190.00 in a research note to investors on Friday. Seven research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $113.11.
Shares of Illumina (NASDAQ:ILMN) traded up 7.78% on Friday, hitting $135.00. 3,702,177 shares of the company’s stock traded hands. Illumina has a one year low of $48.00 and a one year high of $127.00. The stock’s 50-day moving average is $107. and its 200-day moving average is $88.. The company has a market cap of $17.063 billion and a price-to-earnings ratio of 149.47.
Illumina (NASDAQ:ILMN) last announced its earnings results on Monday, October 21st. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.05. The company had revenue of $357.00 million for the quarter, compared to the consensus estimate of $343.42 million. During the same quarter in the previous year, the company posted $0.41 earnings per share. The company’s revenue for the quarter was up 24.9% on a year-over-year basis. Analysts expect that Illumina will post $1.78 EPS for the current fiscal year.
In other Illumina news, CEO Jay Flatley sold 30,000 shares of Illumina stock in a transaction that occurred on Thursday, January 9th. The stock was sold at an average price of $114.77, for a total value of $3,443,100.00. Following the sale, the chief executive officer now directly owns 399,509 shares of the company’s stock, valued at approximately $45,851,648. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.